Answer
Efavirenz is contraindicated with elbasvir/grazoprevir because CYP3A4 induction significantly decreases elbasvir and grazoprevir plasma concentrations, potentially causing loss of virologic response.
Sources for this answer
- Efavirenz 600 mg film-coated tabletsAurobindo Pharma - Milpharm Ltd. · emc · SmPC §4.5 Interaction with other medicinal products · Version 12Document updated
Sources checked